---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-26-039943"
form_type: "8-K"
ticker: "INM"
cik: "0001728328"
company_name: "InMed Pharmaceuticals Inc."
filed_at: "2026-04-03T23:59:59+00:00"
generated_at: "2026-05-15T07:38:27.337252+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.45
calibrated_materiality_score: 0.45
confidence: "high"
source: SEC EDGAR
---

# InMed files prospectus supplement for ATM offering of common shares under existing Sales Agreement

## Summary
- Filed prospectus supplement dated April 3, 2026 for at-the-market equity offering.
- ATM facility is under Sales Agreement with H.C. Wainwright & Co., originally dated April 7, 2022, amended June 27, 2024.
- Shelf registration statement on Form S-3 (File No. 333-294503) declared effective March 30, 2026.
- No specific number of shares or dollar amount disclosed in the filing.

## SEC filing metadata
- accession: 0001213900-26-039943
- form_type: 8-K
- ticker: INM
- cik: 0001728328
- company_name: InMed Pharmaceuticals Inc.
- filed_at: 2026-04-03T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.45
- calibrated_materiality_score: 0.45
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1728328/000121390026039943/0001213900-26-039943-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1728328/000121390026039943/ea0284989-8k_inmed.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-26-039943
- JSON: https://secwatch.observer/filing/0001213900-26-039943.json
- Plain text: https://secwatch.observer/filing/0001213900-26-039943.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.